Biocon’s subsidiary, Syngene International, announced that it has entered into a contract research agreement with the Novartis Institut...
Mumbai |
1 min read
Whatsapp
Twitter
Facebook
Reddit
Biocon’s subsidiary, Syngene International, announced that it has entered into a contract research agreement with the Novartis Institutes for Biomedical Research Inc to carry out research projects to support new drug discovery and development.
The contract research agreement was signed recently after a senior contingent from Cambridge, United States, visited Syngene in Bangalore last month.
You have exhausted your monthly limit of free stories.
Read more stories for free with an Express account.
